MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
Univalor
Parents
*Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
WBT: Candidate Companies (2008)
Children
A new target and compounds for treating age-related macular degeneration.
Besides being the first class of specific CD36 modulator, the technology introduces a new approach for treating AMD by aiming at a new biological target.
The technology is a unique class of selective CD36 modulators that are novel drug candidates for treating age-related macular degeneration (AMD).